TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling

por Kawabata, Hidetaka, Azuma, Kotaro, Ikeda, Kazuhiro, Sugitani, Ikuko, Kinowaki, Keiichi, Fujii, Takeshi, Osaki, Akihiko, Saeki, Toshiaki, Horie-Inoue, Kuniko, Inoue, Satoshi
Publicado 2017

Intracellular hypoxia measured by (18)F-fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen receptor-positive breast cancer

por Asano, Aya, Ueda, Shigeto, Kuji, Ichiei, Yamane, Tomohiko, Takeuchi, Hideki, Hirokawa, Eiko, Sugitani, Ikuko, Shimada, Hiroko, Hasebe, Takahiro, Osaki, Akihiko, Saeki, Toshiaki
Publicado 2018

Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR...

por Asano, Aya, Ueda, Shigeto, Kuji, Ichiei, Yamane, Tomohiko, Takeuchi, Hideki, Hirokawa, Eiko, Sugitani, Ikuko, Shimada, Hiroko, Hasebe, Takahiro, Osaki, Akihiko, Saeki, Toshiaki
Publicado 2018

Neoadjuvant chemotherapy with trastuzumab, docetaxel, and carboplatin administered every 3 weeks for Japanese women with HER2-positive primary breast cancer: efficacy and safety

por Sugitani, Ikuko, Ueda, Shigeto, Sakurai, Takashi, Shigekawa, Takashi, Hirokawa, Eiko, Shimada, Hiroko, Takeuchi, Hideki, Matsuura, Kazuo, Misumi, Misono, Fujiuchi, Nobuko, Takahashi, Takao, Hasebe, Takahiro, Osaki, Akihiko, Saeki, Toshiaki
Publicado 2017

Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility study

por Shigekawa, Takashi, Osaki, Akihiko, Sekine, Hiroshi, Sato, Nobuaki, Kanbayashi, Chizuko, Sano, Hiroshi, Takeuchi, Hideki, Ueda, Shigeto, Nakamiya, Noriko, Sugitani, Ikuko, Sugiyama, Michiko, Shimada, Hiroko, Hirokawa, Eiko, Takahashi, Takao, Saeki, Toshiaki
Publicado 2015